Safety, Tolerability and Efficacy of TV-1106 in Adults With Growth Hormone Deficiency

Study Title
Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
Teva Identifier
TV1106-GHD-201 | 2012-004975-37
ClinicalTrials.gov Identifier
NCT01811576
Study Status
Completed
Trial Condition(s)
Growth Hormone Deficiency
Interventions
Drug: TV-1106 | Drug: Recombinant human growth hormone

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
23 Years to 65 Years
Trial Duration
March 31, 2013 - August 5, 2013
Phase
Phase 2

Study Type

Interventional